Brief: Foghorn Therapeutics Says Received IND Clearance For FHD-609
May 11 (Reuters) - Foghorn Therapeutics Inc. FHTX.O :
* FOGHORN THERAPEUTICS INC. - RECEIVED IND CLEARANCE FOR
FHD-609
* FOGHORN THERAPEUTICS INC. - CONTINUED TO ADVANCE BROAD
THERAPEUTIC PIPELINE TARGETING CHROMATIN REGULATORY SYSTEM
* FOGHORN THERAPEUTICS INC. - REPORTED CASH, CASH
EQUIVALENTS AND
MARKETABLE SECURITIES OF $ 160.9 MILLION AS OF MARCH 31, 2021
Source text for Eikon: ID:nGNX8S52rb
Further company coverage: FHTX.O
((Reuters.Briefs@thomsonreuters.com;))